MON4STRAT | MON4STRAT— Therapeutic Beta-Lactam Monitoring for Stratified Treatment of hospital-acquired pneumonia, improved dose-dependent efficacy, decreased treatment duration, and prevention of emergence of resistance

This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602906.

Call identifier
FP7-HEALTH-2013-INNOVATION-1
HEALTH.2013.2.3.1-2 :Stratified approaches to antibacterial and/or antifungal treatment
Funding scheme
Collaborative project

MON4STRAT— Therapeutic Beta-Lactam Monitoring for Stratified Treatment of hospital-acquired pneumonia, improved dose-dependent efficacy, decreased treatment duration, and prevention of emergence of resistance

MON4STRAT— Therapeutic Beta-Lactam Monitoring for Stratified Treatment of hospital-acquired pneumonia, improved dose-dependent efficacy, decreased treatment duration, and prevention of emergence of resistance

MON4STRAT— Therapeutic Beta-Lactam Monitoring for Stratified Treatment of hospital-acquired pneumonia, improved dose-dependent efficacy, decreased treatment duration, and prevention of emergence of resistance

Actual State-of-the-Art

Expected progresses

The partners